Identity confirmed with an official business registry. How we verify
Werfen, based in Spain, offers a Hemostasis product line made up of in vitro diagnostic systems, reagents, information management and services, used to diagnose and guide treatment of thrombotic and bleeding disorders. The company also serves acute care, transfusion, autoimmunity and transplant diagnostics. On October 16, 2024, Werfen completed the acquisition of Omixon, a privately held company in Budapest, Hungary, which develops and commercializes Next Generation Sequencing technologies for transplant diagnostics.
Description based on the company's website.
Official data
- Registry
- GLEIF
- Number
- 9598003BHZ02SG7LKD16
- Legal name
- WERFEN S.A.
- Verified on
Products manufactured
Product illustrations, until the company adds its own photos.
The factor-by-factor breakdown, the comparison of your suppliers and alerts are reserved for buyer accounts. See the details and compare
Request a quote
Contact via Tritonis: the Tritonis team forwards your request to Werfen and follows it up until it gets a reply. It also goes right away to the other suppliers ticked below. Indicative forwarding time: 5 business days.
Other suppliers: Miscellaneous diagnostic and laboratory reagents
-
ITW ReagentsMain product at 0% Canadian duty
-
CondalabMain product at 0% Canadian duty
See all suppliers of this product
Spotted an error on this listing?
Report it: we review every report, usually within two business days. No account is needed.
Recently viewed



